Q4 2024 · 13F-HR
Darwin Global Management, Ltd.holdings as filed
Filed 2025-02-14 · accession 0001892688-25-000094
$1.06B
Reported value
6
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 457669307 | INSM | INSMED INC | $894.8M | 84.8% | 12,960,538 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $59.7M | 5.65% | 484,515 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $37.6M | 3.56% | 810,449 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $33.9M | 3.21% | 9,569,835 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $26.7M | 2.53% | 1,687,135 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $3.1M | 0.29% | 163,681 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.